{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:52:39Z","timestamp":1779166359166,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,3,24]],"date-time":"2009-03-24T00:00:00Z","timestamp":1237852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s12032-009-9207-y","type":"journal-article","created":{"date-parts":[[2009,3,23]],"date-time":"2009-03-23T15:41:00Z","timestamp":1237822860000},"page":"291-295","source":"Crossref","is-referenced-by-count":40,"title":["Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter\u00a0pylori therapy"],"prefix":"10.1007","volume":"27","author":[{"given":"Angelo","family":"Zullo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Andriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Cristofari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Bassanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Paolo","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silverio","family":"Tomao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Morini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,24]]},"reference":[{"key":"9207_CR1","doi-asserted-by":"crossref","unstructured":"Cavalli F, et\u00a0al. MALT lymphomas. Hematology Am Soc Hematol Educ Program. 2001;241\u201358. doi: 10.1182\/asheducation-2001.1.241 .","DOI":"10.1182\/asheducation-2001.1.241"},{"issue":"Suppl 3","key":"9207_CR2","first-page":"19","volume":"50","author":"M Stolte","year":"2002","unstructured":"Stolte M, et al. Helicobacter\u00a0pylori and gastric MALT lymphoma. Gut. 2002;50(Suppl 3):19\u201324. doi: 10.1136\/gut.50.suppl_3.iii19 .","journal-title":"Gut"},{"key":"9207_CR3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2036.2006.02826.x","volume":"23","author":"A Andriani","year":"2006","unstructured":"Andriani A, et al. Clinical and endoscopic presentation of primary gastric lymphoma: a multicentre study. Aliment Pharmacol Ther. 2006;23:721\u20136. doi: 10.1111\/j.1365-2036.2006.02826.x .","journal-title":"Aliment Pharmacol Ther"},{"key":"9207_CR4","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","volume":"56","author":"P Malfertheiner","year":"2007","unstructured":"Malfertheiner P, et al. Current concepts in the management of Helicobacter\u00a0pylori infection\u2014the Maastricht III consensus report. Gut. 2007;56:772\u201381. doi: 10.1136\/gut.2006.101634 .","journal-title":"Gut"},{"key":"9207_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1572-0241.2007.01057.x","volume":"102","author":"WD Chey","year":"2007","unstructured":"Chey WD, Wong BCY. American College of Gastroenterology guideline on the management of Helicobacter\u00a0pylori infection. Am J Gastroenterol. 2007;102:1\u201318. doi: 10.1111\/j.1572-0241.2007.01393.x .","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 17","key":"9207_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00535-006-1938-3","volume":"42","author":"T Fujioka","year":"2007","unstructured":"Fujioka T, et al. Guidelines for the management of Helicobacter pylori infection in Japan: current status and future prospects. J Gastroenterol. 2007;42(Suppl 17):3\u20136. doi: 10.1007\/s00535-006-1938-3 .","journal-title":"J Gastroenterol"},{"key":"9207_CR7","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.dld.2007.05.016","volume":"39","author":"M Caselli","year":"2007","unstructured":"Caselli M, et al. Cervia II Working Group Report 2006: guidelines on diagnosis and treatment of Helicobacter\u00a0pylori infection in Italy. Dig Liver Dis. 2007;39:782\u20139. doi: 10.1016\/j.dld.2007.05.016 .","journal-title":"Dig Liver Dis"},{"key":"9207_CR8","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1080\/10428190600774873","volume":"47","author":"PL Zinzani","year":"2006","unstructured":"Zinzani PL. Thoughts on the eradication of Helicobacter\u00a0pylori infection in localized gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma. 2006;47:2013\u20134. doi: 10.1080\/10428190600774873 .","journal-title":"Leuk Lymphoma"},{"key":"9207_CR9","unstructured":"Andriani A, et\u00a0al. Management and long-term follow up of early stage H.\u00a0pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicenter study. Dig Liver Dis. 2008 [Epub ahead of print]."},{"key":"9207_CR10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/978-3-642-57054-4_15","volume":"156","author":"A Savio","year":"2000","unstructured":"Savio A, et al. Relapse of low-grade gastric MALT lymphoma after Helicobacter\u00a0pylori eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol\u2019s adequacy. Recent Results Cancer Res. 2000;156:116\u201324.","journal-title":"Recent Results Cancer Res"},{"key":"9207_CR11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00004836-200009000-00018","volume":"31","author":"A Papa","year":"2000","unstructured":"Papa A, et al. Helicobacter\u00a0pylori eradication and remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma: a long-term follow-up study. J Clin Gastroenterol. 2000;31:169\u201371. doi: 10.1097\/00004836-200009000-00018 .","journal-title":"J Clin Gastroenterol"},{"key":"9207_CR12","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1046\/j.1365-2036.2002.01334.x","volume":"16","author":"G Caletti","year":"2002","unstructured":"Caletti G, et al. The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphoma. Aliment Pharmacol Ther. 2002;16:1715\u201322. doi: 10.1046\/j.1365-2036.2002.01334.x .","journal-title":"Aliment Pharmacol Ther"},{"key":"9207_CR13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1572-0241.2002.05460.x","volume":"97","author":"M Levy","year":"2002","unstructured":"Levy M, et al. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. Am J Gastroenterol. 2002;97:292\u20137. doi: 10.1111\/j.1572-0241.2002.05460.x .","journal-title":"Am J Gastroenterol"},{"key":"9207_CR14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/cncr.21152","volume":"104","author":"S Nakamura","year":"2005","unstructured":"Nakamura S, et al. Long-term clinical outcome of Helicobacter\u00a0pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Cancer. 2005;104:532\u201340. doi: 10.1002\/cncr.21152 .","journal-title":"Cancer"},{"key":"9207_CR15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1523-5378.2006.00382.x","volume":"11","author":"T Akamatsu","year":"2006","unstructured":"Akamatsu T, et al. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter\u00a0pylori infection. Helicobacter. 2006;11:86\u201395. doi: 10.1111\/j.1523-5378.2006.00382.x .","journal-title":"Helicobacter"},{"key":"9207_CR16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.7326\/0003-4819-131-2-199907200-00003","volume":"131","author":"G Steinbach","year":"1999","unstructured":"Steinbach G, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue: an uncontrolled trial. Ann Intern Med. 1999;131:88\u201395.","journal-title":"Ann Intern Med"},{"key":"9207_CR17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2169\/internalmedicine.45.1473","volume":"45","author":"M Sugimoto","year":"2006","unstructured":"Sugimoto M, et al. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter\u00a0pylori eradication therapy. Intern Med. 2006;45:405\u20139. doi: 10.2169\/internalmedicine.45.1473 .","journal-title":"Intern Med"},{"key":"9207_CR18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1023\/A:1011122904602","volume":"12","author":"M Raderer","year":"2001","unstructured":"Raderer M, et al. Impaired response of gastric MALT-lymphoma to Helicobacter\u00a0pylori eradication in patients with autoimmune disease. Ann Oncol. 2001;12:937\u20139. doi: 10.1023\/A:1011122904602 .","journal-title":"Ann Oncol"},{"key":"9207_CR19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1620\/tjem.214.79","volume":"214","author":"S Terai","year":"2008","unstructured":"Terai S, et al. Long-term outcomes of gastric mucosa-associated lymphoid tissue lymphomas after Helicobacter\u00a0pylori eradication therapy. Tohoku J Exp Med. 2008;214:79\u201387. doi: 10.1620\/tjem.214.79 .","journal-title":"Tohoku J Exp Med"},{"key":"9207_CR20","first-page":"36","volume":"47","author":"S Begum","year":"2000","unstructured":"Begum S, et al. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter\u00a0pylori: follow-up study of 48 cases. J Med Invest. 2000;47:36\u201346.","journal-title":"J Med Invest"},{"key":"9207_CR21","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s004640000239","volume":"14","author":"F Agresta","year":"2000","unstructured":"Agresta F, et al. Gastric MALT lymphomas: the value of an endoscopic follow-up evaluation. Surg Endosc. 2000;14:1153\u20135. doi: 10.1007\/s004640000239 .","journal-title":"Surg Endosc"},{"key":"9207_CR22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.gie.2006.05.009","volume":"65","author":"LM El-Zahabi","year":"2007","unstructured":"El-Zahabi LM, et al. The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter\u00a0pylori eradication. Gastrointest Endosc. 2007;65:89\u201396. doi: 10.1016\/j.gie.2006.05.009 .","journal-title":"Gastrointest Endosc"},{"key":"9207_CR23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH811>3.0.CO;2-Z","volume":"193","author":"D Jong de","year":"2001","unstructured":"de Jong D, et al. Histological and immunological parameters to predict treatment outcome of Helicobacter\u00a0pylori eradication in low-grade gastric MALT lymphoma. J Pathol. 2001;193:318\u201324. doi: 10.1002\/1096-9896(2000)9999:9999<::AID-PATH811>3.0.CO;2-Z .","journal-title":"J Pathol"},{"key":"9207_CR24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1542-3565(05)00185-0","volume":"3","author":"Y Kawahara","year":"2005","unstructured":"Kawahara Y, et al. HLA-DQA1*0103-DQB1*0601 haplotype and Helicobacter\u00a0pylori-positive gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol. 2005;3:865\u20138. doi: 10.1016\/S1542-3565(05)00185-0 .","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9207_CR25","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s005350200062","volume":"37","author":"Y Matsushima","year":"2002","unstructured":"Matsushima Y, et al. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach Are there any useful markers for predicting outcome after Helicobacter\u00a0pylori eradication? J Gastroenterol. 2002;37:428\u201333. doi: 10.1007\/s005350200062 .","journal-title":"J Gastroenterol"},{"key":"9207_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s535-002-8127-8","volume":"37","author":"YS Kim","year":"2002","unstructured":"Kim YS, et al. Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter\u00a0pylori: possible association with p16 hypermethylation. J Gastroenterol. 2002;37:17\u201322. doi: 10.1007\/s535-002-8127-8 .","journal-title":"J Gastroenterol"},{"key":"9207_CR27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1523-5378.2003.00122.x","volume":"8","author":"BS Sheu","year":"2003","unstructured":"Sheu BS, et al. Clinical application of 20 MHZ endosonography and anti-Helicobacter\u00a0pylori immunoblots to predict regression of low-grade gastric Maltoma by H.\u00a0pylori eradication. Helicobacter. 2003;8:36\u201345. doi: 10.1046\/j.1523-5378.2003.00122.x .","journal-title":"Helicobacter"},{"key":"9207_CR28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/003655202317284174","volume":"37","author":"S Ohashi","year":"2002","unstructured":"Ohashi S, et al. Gastrin and Helicobacter\u00a0pylori in low-grade MALT lymphoma patients. Scand J Gastroenterol. 2002;37:279\u201386. doi: 10.1080\/003655202317284174 .","journal-title":"Scand J Gastroenterol"},{"key":"9207_CR29","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1080\/10428190600783536","volume":"47","author":"T W\u00fcndisch","year":"2006","unstructured":"W\u00fcndisch T, et al. Helicobacter\u00a0pylori eradication in gastric mucosa-associated lymphoid tissue lymphoma: results of a 196-patient series. Leuk Lymphoma. 2006;47:2110\u20134. doi: 10.1080\/10428190600783536 .","journal-title":"Leuk Lymphoma"},{"key":"9207_CR30","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/annonc\/mdi277","volume":"16","author":"C Montalban","year":"2005","unstructured":"Montalban C, et al. Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H.\u00a0pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study. Ann Oncol. 2005;16:1539\u201344. doi: 10.1093\/annonc\/mdi277 .","journal-title":"Ann Oncol"},{"key":"9207_CR31","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s12185-008-0187-z","volume":"88","author":"G Dong","year":"2008","unstructured":"Dong G, et al. BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter\u00a0pylori eradication of Chinese primary gastric MALT lymphoma. Int J Hematol. 2008;88:516\u201323. doi: 10.1007\/s12185-008-0187-z .","journal-title":"Int J Hematol"},{"key":"9207_CR32","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1200\/JCO.2005.10.018","volume":"23","author":"A Noy","year":"2005","unstructured":"Noy A, et al. Gastric mucosa-associated lymphoid tissue lymphoma detected by clonotypic polymerase chain reaction despite continuous pathologic remission induced by involved-field radiotherapy. J Clin Oncol. 2005;23:3768\u201372. doi: 10.1200\/JCO.2005.10.018 .","journal-title":"J Clin Oncol"},{"key":"9207_CR33","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1200\/JCO.1998.16.5.1916","volume":"16","author":"NR Schechter","year":"1998","unstructured":"Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol. 1998;16:1916\u201321.","journal-title":"J Clin Oncol"},{"key":"9207_CR34","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1200\/JCO.2002.05.117","volume":"20","author":"G Jager","year":"2002","unstructured":"Jager G, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol. 2002;20:3872\u20137. doi: 10.1200\/JCO.2002.05.117 .","journal-title":"J Clin Oncol"},{"key":"9207_CR35","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2005.08.128","volume":"23","author":"G Martinelli","year":"2005","unstructured":"Martinelli G, et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin\u2019s lymphoma resistant to or not elegible for anti-Helicobacter\u00a0pylori therapy. J Clin Oncol. 2005;23:1979\u201383. doi: 10.1200\/JCO.2005.08.128 .","journal-title":"J Clin Oncol"},{"key":"9207_CR36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00428-005-1217-3","volume":"446","author":"A Mascarel de","year":"2005","unstructured":"de Mascarel A, et al. Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue. Virchows Arch. 2005;446:219\u201324. doi: 10.1007\/s00428-005-1217-3 .","journal-title":"Virchows Arch"},{"key":"9207_CR37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3748\/wjg.v10.i2.223","volume":"10","author":"SK Lee","year":"2004","unstructured":"Lee SK, et al. Low grade gastric mucosa associated lymphoid tissue lymphoma: treatment strategies based on 10\u00a0year follow-up. World J Gastroenterol. 2004;10:223\u20136.","journal-title":"World J Gastroenterol"},{"key":"9207_CR38","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1200\/JCO.2005.02.3903","volume":"23","author":"T W\u00fcndisch","year":"2005","unstructured":"W\u00fcndisch T, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter\u00a0pylori eradication. J Clin Oncol. 2005;23:8018\u201324. doi: 10.1200\/JCO.2005.02.3903 .","journal-title":"J Clin Oncol"},{"key":"9207_CR39","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1523-5378.2006.00460.x","volume":"11","author":"SS Hong","year":"2006","unstructured":"Hong SS, et al. A prospective analysis of low-grade gastric MALT lymphoma after Helicobacter\u00a0pylori eradication. Helicobacter. 2006;11:569\u201373. doi: 10.1111\/j.1523-5378.2006.00460.x .","journal-title":"Helicobacter"},{"key":"9207_CR40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gut.53.1.34","volume":"53","author":"W Fischbach","year":"2004","unstructured":"Fischbach W, et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter\u00a0pylori eradication therapy: experience from a large prospective series. Gut. 2004;53:34\u20137. doi: 10.1136\/gut.53.1.34 .","journal-title":"Gut"},{"key":"9207_CR41","first-page":"899","volume":"15","author":"AP Wenston","year":"1999","unstructured":"Wenston AP, et al. Prospective long-term endoscopic and histologic follow-up of gastric lymphoproliferative disease of early stage I.E low-gared B-cell mucosa-associated lymphoid tissue type following Helicobacter\u00a0pylori eradication treatment. Int J Oncol. 1999;15:899\u2013907.","journal-title":"Int J Oncol"},{"key":"9207_CR42","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1128\/CDLI.8.6.1056-1059.2001","volume":"8","author":"E Ishii","year":"2001","unstructured":"Ishii E, et al. Immunoglobulin G1 antibody response to Helicobacter\u00a0pylori heat shock protein 60 is closely associated with low-grade gastric mucosa-associated lymphoid tissue lymphoma. Clin Diagn Lab Immunol. 2001;8:1056\u20139. doi: 10.1128\/CDLI.8.6.1056-1059.2001 .","journal-title":"Clin Diagn Lab Immunol"},{"key":"9207_CR43","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1182\/blood.V99.7.2541","volume":"99","author":"F Bertoni","year":"2002","unstructured":"Bertoni F, et al. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood. 2002;99:2541\u20134. doi: 10.1182\/blood.V99.7.2541 .","journal-title":"Blood"},{"key":"9207_CR44","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.bjc.6603708","volume":"96","author":"JS Kim","year":"2007","unstructured":"Kim JS, et al. Helicobacter\u00a0pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease. Br J Cancer. 2007;96:1324\u20138.","journal-title":"Br J Cancer"},{"key":"9207_CR45","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1083-4389.2004.00225.x","volume":"9","author":"R Takenaka","year":"2004","unstructured":"Takenaka R, et al. Serum antibodies to Helicobacter\u00a0pylori and its heat-shock protein 60 correlate with the response of gastric mucosa-associated lymphoid tissue lymphoma to eradication of H.\u00a0pylori. Helicobacter. 2004;9:194\u2013200. doi: 10.1111\/j.1083-4389.2004.00225.x .","journal-title":"Helicobacter"},{"key":"9207_CR46","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3109\/10428190109099324","volume":"42","author":"M Kanda","year":"2002","unstructured":"Kanda M, et al. Changes in patterns of immunoglobulin heavy chain gene rearrangement and MIB-1 staining before and after eradication of Helicobacter\u00a0pylori in gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma. 2002;42:639\u201347. doi: 10.3109\/10428190109099324 .","journal-title":"Leuk Lymphoma"},{"key":"9207_CR47","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.gie.2008.02.066","volume":"68","author":"S Ono","year":"2008","unstructured":"Ono S, et al. Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment. Gastrointest Endosc. 2008;68:624\u201331. doi: 10.1016\/j.gie.2008.02.066 .","journal-title":"Gastrointest Endosc"},{"key":"9207_CR48","first-page":"1207","volume":"18","author":"T Hiyama","year":"2001","unstructured":"Hiyama T, et al. Helicobacter\u00a0pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability. Int J Oncol. 2001;18:1207\u201312.","journal-title":"Int J Oncol"},{"key":"9207_CR49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00428-005-1217-3","volume":"446","author":"A de mascarel","year":"2005","unstructured":"de mascarel A, et al. Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue. Virchows Arch. 2005;446:219\u201324.","journal-title":"Virchows Arch"},{"key":"9207_CR50","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/gut.2005.083022","volume":"55","author":"M Raderer","year":"2006","unstructured":"Raderer M, et al. Successful antibiotic treatment of Helicobacter\u00a0pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut. 2006;55:616\u20138. doi: 10.1136\/gut.2005.083022 .","journal-title":"Gut"},{"issue":"Suppl 2","key":"9207_CR51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/annonc\/mdn094","volume":"19","author":"E Zucca","year":"2008","unstructured":"Zucca E, Dreyling M. Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008;19(Suppl 2):70\u20131.","journal-title":"Ann Oncol"},{"key":"9207_CR52","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/gut.2006.096420","volume":"56","author":"W Fischbach","year":"2007","unstructured":"Fischbach W, et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter\u00a0pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut. 2007;56:1685\u20137. doi: 10.1136\/gut.2006.096420 .","journal-title":"Gut"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9207-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-009-9207-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9207-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T01:15:01Z","timestamp":1589678101000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-009-9207-y"}},"subtitle":["A pooled-data analysis"],"short-title":[],"issued":{"date-parts":[[2009,3,24]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["9207"],"URL":"https:\/\/doi.org\/10.1007\/s12032-009-9207-y","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,24]]}}}